U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Links from MedGen

Items: 1 to 100 of 700

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr22:17589433
GRCh38:
Chr22:17108543
IL17RAK408E, K442EImmunodeficiency 51Uncertain significance
(Feb 11, 2020)
criteria provided, single submitter
2.
GRCh37:
Chr22:17589867
GRCh38:
Chr22:17108977
IL17RAImmunodeficiency 51Likely benign
(May 27, 2022)
criteria provided, single submitter
3.
GRCh37:
Chr22:17565982-20052185
Immunodeficiency 51, Vasculitis due to ADA2 deficiencyPathogenic
(Apr 17, 2022)
criteria provided, single submitter
4.
GRCh37:
Chr22:17589519
GRCh38:
Chr22:17108629
IL17RAImmunodeficiency 51Likely benign
(Jun 29, 2022)
criteria provided, single submitter
5.
GRCh37:
Chr22:17566056
GRCh38:
Chr22:17085166
IL17RAImmunodeficiency 51Likely benign
(Feb 22, 2022)
criteria provided, single submitter
6.
GRCh37:
Chr22:17582947
GRCh38:
Chr22:17102057
IL17RAImmunodeficiency 51Likely benign
(Sep 13, 2022)
criteria provided, single submitter
7.
GRCh37:
Chr22:17586730
GRCh38:
Chr22:17105840
IL17RAImmunodeficiency 51Likely benign
(Jul 5, 2022)
criteria provided, single submitter
8.
GRCh37:
Chr22:17589908
GRCh38:
Chr22:17109018
IL17RAS600C, S566CImmunodeficiency 51Uncertain significance
(May 5, 2022)
criteria provided, single submitter
9.
GRCh37:
Chr22:17589816
GRCh38:
Chr22:17108926
IL17RAImmunodeficiency 51Likely benign
(Oct 17, 2022)
criteria provided, single submitter
10.
GRCh37:
Chr22:17586501
GRCh38:
Chr22:17105611
IL17RAImmunodeficiency 51Likely benign
(Sep 7, 2022)
criteria provided, single submitter
11.
GRCh37:
Chr22:17588618
GRCh38:
Chr22:17107728
IL17RA, LOC126863094Immunodeficiency 51Likely benign
(May 15, 2022)
criteria provided, single submitter
12.
GRCh37:
Chr22:17578668
GRCh38:
Chr22:17097778
IL17RAImmunodeficiency 51Likely benign
(Jun 10, 2022)
criteria provided, single submitter
13.
GRCh37:
Chr22:17584386
GRCh38:
Chr22:17103496
IL17RAImmunodeficiency 51Benign
(Sep 21, 2022)
criteria provided, single submitter
14.
GRCh37:
Chr22:17582871
GRCh38:
Chr22:17101981
IL17RAImmunodeficiency 51Likely benign
(Apr 1, 2022)
criteria provided, single submitter
15.
GRCh37:
Chr22:17590120
GRCh38:
Chr22:17109230
IL17RAA637T, A671TImmunodeficiency 51Uncertain significance
(Aug 23, 2022)
criteria provided, single submitter
16.
GRCh37:
Chr22:17590092
GRCh38:
Chr22:17109202
IL17RAImmunodeficiency 51Likely benign
(Apr 9, 2022)
criteria provided, single submitter
17.
GRCh37:
Chr22:17589881
GRCh38:
Chr22:17108991
IL17RAY557S, Y591SImmunodeficiency 51Uncertain significance
(May 3, 2022)
criteria provided, single submitter
18.
GRCh37:
Chr22:17589806
GRCh38:
Chr22:17108916
IL17RAQ566R, Q532RImmunodeficiency 51Uncertain significance
(May 13, 2022)
criteria provided, single submitter
19.
GRCh37:
Chr22:17586804
GRCh38:
Chr22:17105914
IL17RAImmunodeficiency 51Likely benign
(Apr 28, 2022)
criteria provided, single submitter
20.
GRCh37:
Chr22:17565990
GRCh38:
Chr22:17085100
IL17RAImmunodeficiency 51Likely benign
(Mar 23, 2022)
criteria provided, single submitter
21.
GRCh37:
Chr22:17590405
GRCh38:
Chr22:17109515
IL17RAG732R, G766RImmunodeficiency 51Uncertain significance
(Jul 14, 2022)
criteria provided, single submitter
22.
GRCh37:
Chr22:17589455
GRCh38:
Chr22:17108565
IL17RAR415H, R449HInborn genetic diseases, Immunodeficiency 51Uncertain significance
(Aug 30, 2022)
criteria provided, multiple submitters, no conflicts
23.
GRCh37:
Chr22:17578820
GRCh38:
Chr22:17097930
IL17RAImmunodeficiency 51Likely benign
(Apr 21, 2022)
criteria provided, single submitter
24.
GRCh37:
Chr22:17589848
GRCh38:
Chr22:17108958
IL17RAR580H, R546HImmunodeficiency 51Uncertain significance
(Jun 27, 2022)
criteria provided, single submitter
25.
GRCh37:
Chr22:17586738
GRCh38:
Chr22:17105848
IL17RAImmunodeficiency 51Uncertain significance
(Dec 21, 2021)
criteria provided, single submitter
26.
GRCh37:
Chr22:17578799
GRCh38:
Chr22:17097909
IL17RAImmunodeficiency 51Likely benign
(Nov 1, 2022)
criteria provided, single submitter
27.
GRCh37:
Chr22:17590489
GRCh38:
Chr22:17109599
IL17RAQ794E, Q760EImmunodeficiency 51Uncertain significance
(Apr 10, 2022)
criteria provided, single submitter
28.
GRCh37:
Chr22:17590261
GRCh38:
Chr22:17109371
IL17RAF684V, F718VInborn genetic diseases, Immunodeficiency 51Uncertain significance
(Sep 19, 2022)
criteria provided, multiple submitters, no conflicts
29.
GRCh37:
Chr22:17565998
GRCh38:
Chr22:17085108
IL17RAS6NImmunodeficiency 51Uncertain significance
(Jun 17, 2022)
criteria provided, single submitter
30.
GRCh37:
Chr22:17589961
GRCh38:
Chr22:17109071
IL17RAV584L, V618LImmunodeficiency 51Uncertain significance
(Aug 6, 2022)
criteria provided, single submitter
31.
GRCh37:
Chr22:17589713
GRCh38:
Chr22:17108823
IL17RAR501H, R535HImmunodeficiency 51Uncertain significance
(Mar 9, 2022)
criteria provided, single submitter
32.
GRCh37:
Chr22:17590558
GRCh38:
Chr22:17109668
IL17RAE783K, E817KImmunodeficiency 51Uncertain significance
(Feb 3, 2022)
criteria provided, single submitter
33.
GRCh37:
Chr22:17579724
GRCh38:
Chr22:17098834
IL17RAR124CImmunodeficiency 51Uncertain significance
(May 12, 2022)
criteria provided, single submitter
34.
GRCh37:
Chr22:17590264
GRCh38:
Chr22:17109374
IL17RAL685F, L719FImmunodeficiency 51Uncertain significance
(Aug 23, 2022)
criteria provided, single submitter
35.
GRCh37:
Chr22:17583012
GRCh38:
Chr22:17102122
IL17RAImmunodeficiency 51Likely benign
(Jun 11, 2022)
criteria provided, single submitter
36.
GRCh37:
Chr22:17566053
GRCh38:
Chr22:17085163
IL17RAImmunodeficiency 51Likely benign
(Aug 19, 2022)
criteria provided, single submitter
37.
GRCh37:
Chr22:17590600
GRCh38:
Chr22:17109710
IL17RAE797K, E831KImmunodeficiency 51Uncertain significance
(Jun 4, 2022)
criteria provided, single submitter
38.
GRCh37:
Chr22:17590697
GRCh38:
Chr22:17109807
IL17RAG829A, G863AImmunodeficiency 51Uncertain significance
(Mar 11, 2022)
criteria provided, single submitter
39.
GRCh37:
Chr22:17584446
GRCh38:
Chr22:17103556
IL17RAImmunodeficiency 51Likely benign
(Apr 29, 2022)
criteria provided, single submitter
40.
GRCh37:
Chr22:17590048
GRCh38:
Chr22:17109158
IL17RAV613M, V647MImmunodeficiency 51Uncertain significance
(Apr 21, 2022)
criteria provided, single submitter
41.
GRCh37:
Chr22:17578853
GRCh38:
Chr22:17097963
IL17RAImmunodeficiency 51Likely benign
(Sep 19, 2022)
criteria provided, single submitter
42.
GRCh37:
Chr22:17589576
GRCh38:
Chr22:17108686
IL17RAD489E, D455EImmunodeficiency 51Uncertain significance
(Jul 4, 2022)
criteria provided, single submitter
43.
GRCh37:
Chr22:17589664
GRCh38:
Chr22:17108774
IL17RAA519P, A485PImmunodeficiency 51Uncertain significance
(Mar 28, 2022)
criteria provided, single submitter
44.
GRCh37:
Chr22:17590427
GRCh38:
Chr22:17109537
IL17RAM773R, M739RImmunodeficiency 51Uncertain significance
(Dec 14, 2021)
criteria provided, single submitter
45.
GRCh37:
Chr22:17589492
GRCh38:
Chr22:17108602
IL17RAImmunodeficiency 51Likely benign
(May 5, 2022)
criteria provided, single submitter
46.
GRCh37:
Chr22:17590382
GRCh38:
Chr22:17109492
IL17RAQ724R, Q758RImmunodeficiency 51Uncertain significance
(Mar 10, 2022)
criteria provided, single submitter
47.
GRCh37:
Chr22:17590361
GRCh38:
Chr22:17109471
IL17RAL717W, L751WImmunodeficiency 51Uncertain significance
(Mar 1, 2022)
criteria provided, single submitter
48.
GRCh37:
Chr22:17590218
GRCh38:
Chr22:17109328
IL17RAImmunodeficiency 51Likely benign
(Feb 23, 2022)
criteria provided, single submitter
49.
GRCh37:
Chr22:17590385
GRCh38:
Chr22:17109495
IL17RAS725N, S759NImmunodeficiency 51Uncertain significance
(Feb 22, 2022)
criteria provided, single submitter
50.
GRCh37:
Chr22:17581283
GRCh38:
Chr22:17100393
IL17RAImmunodeficiency 51Likely benign
(Aug 23, 2022)
criteria provided, single submitter
51.
GRCh37:
Chr22:17589924-17589925
GRCh38:
Chr22:17109034-17109035
IL17RAE607*, E573*Immunodeficiency 51Uncertain significance
(Jan 21, 2022)
criteria provided, single submitter
52.
GRCh37:
Chr22:17583073
GRCh38:
Chr22:17102183
IL17RAH215YImmunodeficiency 51Uncertain significance
(Jan 18, 2022)
criteria provided, single submitter
53.
GRCh37:
Chr22:17583110-17583111
GRCh38:
Chr22:17102220-17102221
IL17RAT228fsImmunodeficiency 51Pathogenic
(Apr 19, 2022)
criteria provided, single submitter
54.
GRCh37:
Chr22:17585679
GRCh38:
Chr22:17104789
IL17RAP304SImmunodeficiency 51Uncertain significance
(Jan 15, 2022)
criteria provided, single submitter
55.
GRCh37:
Chr22:17590207
GRCh38:
Chr22:17109317
IL17RAG666S, G700SImmunodeficiency 51Uncertain significance
(Jan 13, 2022)
criteria provided, single submitter
56.
GRCh37:
Chr22:17589983
GRCh38:
Chr22:17109093
IL17RAR591H, R625HImmunodeficiency 51Uncertain significance
(Oct 17, 2022)
criteria provided, single submitter
57.
GRCh37:
Chr22:17577939
GRCh38:
Chr22:17097049
IL17RAImmunodeficiency 51Likely benign
(Sep 12, 2022)
criteria provided, single submitter
58.
GRCh37:
Chr22:17589689
GRCh38:
Chr22:17108799
IL17RAD493G, D527GImmunodeficiency 51Uncertain significance
(Mar 12, 2022)
criteria provided, single submitter
59.
GRCh37:
Chr22:17590257
GRCh38:
Chr22:17109367
IL17RAImmunodeficiency 51Likely benign
(Jan 4, 2022)
criteria provided, single submitter
60.
GRCh37:
Chr22:17590354
GRCh38:
Chr22:17109464
IL17RAE715Q, E749QImmunodeficiency 51Uncertain significance
(Aug 5, 2022)
criteria provided, single submitter
61.
GRCh37:
Chr22:17586789
GRCh38:
Chr22:17105899
IL17RAImmunodeficiency 51Likely benign
(Jun 19, 2022)
criteria provided, single submitter
62.
GRCh37:
Chr22:17590423
GRCh38:
Chr22:17109533
IL17RAA738T, A772TImmunodeficiency 51Uncertain significance
(Jan 2, 2022)
criteria provided, single submitter
63.
GRCh37:
Chr22:17566022
GRCh38:
Chr22:17085132
IL17RAP14RImmunodeficiency 51Uncertain significance
(Jun 20, 2022)
criteria provided, single submitter
64.
GRCh37:
Chr22:17579715
GRCh38:
Chr22:17098825
IL17RAT121AImmunodeficiency 51Uncertain significance
(Dec 30, 2021)
criteria provided, single submitter
65.
GRCh37:
Chr22:17586724
GRCh38:
Chr22:17105834
IL17RAImmunodeficiency 51Likely benign
(Sep 21, 2022)
criteria provided, single submitter
66.
GRCh37:
Chr22:17590000
GRCh38:
Chr22:17109110
IL17RAA597T, A631TImmunodeficiency 51Uncertain significance
(Dec 14, 2021)
criteria provided, single submitter
67.
GRCh37:
Chr22:17585644
GRCh38:
Chr22:17104754
IL17RAN292SImmunodeficiency 51Uncertain significance
(Jun 2, 2022)
criteria provided, single submitter
68.
GRCh37:
Chr22:17590067
GRCh38:
Chr22:17109177
IL17RAH619R, H653RImmunodeficiency 51Uncertain significance
(Oct 24, 2022)
criteria provided, single submitter
69.
GRCh37:
Chr22:17589784
GRCh38:
Chr22:17108894
IL17RAImmunodeficiency 51Likely benign
(Aug 28, 2022)
criteria provided, single submitter
70.
GRCh37:
Chr22:17590580
GRCh38:
Chr22:17109690
IL17RAP790Q, P824QImmunodeficiency 51Uncertain significance
(Aug 10, 2022)
criteria provided, single submitter
71.
GRCh37:
Chr22:17578779
GRCh38:
Chr22:17097889
IL17RAQ86KImmunodeficiency 51Uncertain significance
(Sep 19, 2022)
criteria provided, single submitter
72.
GRCh37:
Chr22:17590064
GRCh38:
Chr22:17109174
IL17RAP618R, P652RImmunodeficiency 51Uncertain significance
(Apr 23, 2022)
criteria provided, multiple submitters, no conflicts
73.
GRCh37:
Chr22:17566064
GRCh38:
Chr22:17085174
IL17RAP28LImmunodeficiency 51Uncertain significance
(Jan 17, 2022)
criteria provided, single submitter
74.
GRCh37:
Chr22:17590590
GRCh38:
Chr22:17109700
IL17RAImmunodeficiency 51Likely benign
(Jul 25, 2022)
criteria provided, single submitter
75.
GRCh37:
Chr22:17590187
GRCh38:
Chr22:17109297
IL17RAR693P, R659PImmunodeficiency 51Uncertain significance
(Mar 18, 2022)
criteria provided, single submitter
76.
GRCh37:
Chr22:17589879
GRCh38:
Chr22:17108989
IL17RAImmunodeficiency 51Likely benign
(Sep 30, 2022)
criteria provided, single submitter
77.
GRCh37:
Chr22:17589795
GRCh38:
Chr22:17108905
IL17RAImmunodeficiency 51Likely benign
(Jul 23, 2022)
criteria provided, single submitter
78.
GRCh37:
Chr22:17579708
GRCh38:
Chr22:17098818
IL17RAQ118HImmunodeficiency 51Uncertain significance
(Jul 6, 2022)
criteria provided, single submitter
79.
GRCh37:
Chr22:17590313
GRCh38:
Chr22:17109423
IL17RAA701V, A735VImmunodeficiency 51Uncertain significance
(Jul 3, 2022)
criteria provided, single submitter
80.
GRCh37:
Chr22:17583042
GRCh38:
Chr22:17102152
IL17RAImmunodeficiency 51Likely benign
(Jul 2, 2022)
criteria provided, single submitter
81.
GRCh37:
Chr22:17585630
GRCh38:
Chr22:17104740
IL17RAImmunodeficiency 51Likely benign
(Jun 27, 2022)
criteria provided, single submitter
82.
GRCh37:
Chr22:17583014
GRCh38:
Chr22:17102124
IL17RAImmunodeficiency 51Likely benign
(Jun 11, 2022)
criteria provided, single submitter
83.
GRCh37:
Chr22:17589666-17589667
GRCh38:
Chr22:17108776-17108777
IL17RAY489fs, Y523fsImmunodeficiency 51Uncertain significance
(Jun 9, 2022)
criteria provided, single submitter
84.
GRCh37:
Chr22:17579686
GRCh38:
Chr22:17098796
IL17RAG111VImmunodeficiency 51Uncertain significance
(Jun 3, 2022)
criteria provided, single submitter
85.
GRCh37:
Chr22:17578728
GRCh38:
Chr22:17097838
IL17RAT69fsImmunodeficiency 51Pathogenic
(May 28, 2022)
criteria provided, single submitter
86.
GRCh37:
Chr22:17577934
GRCh38:
Chr22:17097044
IL17RAImmunodeficiency 51Likely benign
(Oct 3, 2022)
criteria provided, single submitter
87.
GRCh37:
Chr22:17590620
GRCh38:
Chr22:17109730
IL17RAImmunodeficiency 51Likely benign
(Jun 22, 2022)
criteria provided, single submitter
88.
GRCh37:
Chr22:17590123
GRCh38:
Chr22:17109233
IL17RAA638T, A672TImmunodeficiency 51Uncertain significance
(Aug 23, 2022)
criteria provided, single submitter
89.
GRCh37:
Chr22:17590162
GRCh38:
Chr22:17109272
IL17RAP651T, P685TImmunodeficiency 51, Inborn genetic diseasesUncertain significance
(Jun 12, 2023)
criteria provided, multiple submitters, no conflicts
90.
GRCh37:
Chr22:17582880
GRCh38:
Chr22:17101990
IL17RAImmunodeficiency 51Likely benign
(Sep 13, 2022)
criteria provided, single submitter
91.
GRCh37:
Chr22:17589877
GRCh38:
Chr22:17108987
IL17RAL590F, L556FImmunodeficiency 51Uncertain significance
(Mar 21, 2022)
criteria provided, single submitter
92.
GRCh37:
Chr22:17590525
GRCh38:
Chr22:17109635
IL17RAE772K, E806KImmunodeficiency 51Uncertain significance
(Feb 6, 2022)
criteria provided, single submitter
93.
GRCh37:
Chr22:17586819
GRCh38:
Chr22:17105929
IL17RAImmunodeficiency 51Likely benign
(May 24, 2022)
criteria provided, single submitter
94.
GRCh37:
Chr22:17590291
GRCh38:
Chr22:17109401
IL17RAL694F, L728FImmunodeficiency 51Uncertain significance
(Oct 4, 2022)
criteria provided, single submitter
95.
GRCh37:
Chr22:17585660
GRCh38:
Chr22:17104770
IL17RAImmunodeficiency 51Likely benign
(Aug 22, 2022)
criteria provided, single submitter
96.
GRCh37:
Chr22:17590416
GRCh38:
Chr22:17109526
IL17RAImmunodeficiency 51Likely benign
(Apr 10, 2022)
criteria provided, single submitter
97.
GRCh37:
Chr22:17585717
GRCh38:
Chr22:17104827
IL17RAImmunodeficiency 51Likely benign
(Aug 19, 2022)
criteria provided, single submitter
98.
GRCh37:
Chr22:17589643
GRCh38:
Chr22:17108753
IL17RAD512N, D478NInborn genetic diseases, Immunodeficiency 51Uncertain significance
(Aug 22, 2022)
criteria provided, multiple submitters, no conflicts
99.
GRCh37:
Chr22:17585665
GRCh38:
Chr22:17104775
IL17RAA299EImmunodeficiency 51Uncertain significance
(May 30, 2022)
criteria provided, single submitter
100.
GRCh37:
Chr22:17590033
GRCh38:
Chr22:17109143
IL17RAE608K, E642KImmunodeficiency 51Uncertain significance
(Jun 26, 2022)
criteria provided, single submitter
Format
Items per page
Sort by
Choose Destination